[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5934 Introduced in House (IH)]

<DOC>






114th CONGRESS
  2d Session
                                H. R. 5934

    To amend the Controlled Substances Act to add certain synthetic 
           substances to schedule I, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 6, 2016

  Mr. Katko (for himself, Mr. Cicilline, and Mr. Dent) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on the Judiciary, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
    To amend the Controlled Substances Act to add certain synthetic 
           substances to schedule I, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Dangerous Synthetic Drug Control Act 
of 2016''.

SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS SCHEDULE I CONTROLLED 
              SUBSTANCES.

    (a) Cannabimimetic Agents.--Schedule I, as set forth in section 
202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended 
in subsection (d)(2)(B)--
            (1) in clause (xiv) by striking ``and'' at the end;
            (2) in clause (xv) by striking the period and inserting a 
        semicolon; and
            (3) by adding at the end the following:
                            ``(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-
                        indol-3-yl)ethanone (JWH-251);
                            ``(xvii) (1-butyl-1H-indol-3-yl)(4-
                        methylnaphthalen-1-yl)methanone (4'-methyl JWH-
                        073);
                            ``(xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-
                        1H-indol-3-yl)ethanone (JWH-302);
                            ``(xix) N-(adamantan-1-yl)-1-(5-
                        fluoropentyl)-1H-indole-3-carboxamide (5F-
                        APICA);
                            ``(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-
                        indole-3-carboxylate (5F-PB-22);
                            ``(xxi) N-(1-amino-3-methyl-1-oxobutan-2-
                        yl)-1-pentyl-1H-indazole-3-carboxamide (AB-
                        PINACA);
                            ``(xxii) N-(naphthalen-1-yl)-1-pentyl-1H-
                        indole-3-carboxamide (MN-24);
                            ``(xxiii) (1-(5-fluoropentyl)-1H-indazol-3-
                        yl)(naphthalen-1-yl)methanone (THJ-2201);
                            ``(xxiv) N-(1-amino-3,3-dimethyl-1-
                        oxobutan-2-yl)-1-pentyl-1H-indazole-3-
                        carboxamide (ADBICA);
                            ``(xxv) methyl 2-(1-(5-fluoropentyl)-1H-
                        indazole-3-carboxamido)-3-methylbutanoate (5F-
                        AMB); and
                            ``(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-
                        indazole-3-carboxamido)-3-methylbutanoate (MA-
                        CHMINACA).''.
    (b) Synthetic Opioids.--Schedule I, as set forth in section 202(c) 
of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in 
subsection (a) by adding at the end the following:
            ``(43) Butyryl fentanyl.
            ``(44) beta-Hydroxythiofentanyl.
            ``(45) Acetyl fentanyl.''.
    (c) Other Drugs.--Schedule I, as set forth in section 202(c) of the 
Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection 
(c) by adding at the end the following:
            ``(29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one 
        (a-naphyrone).
            ``(30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5-
        APDB).
            ``(31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6-
        APDB).
            ``(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine 
        (MDAI).
            ``(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5-IAI).
            ``(34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine 
        (bromo-dragonfly).
            ``(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine 
        (DOC).
            ``(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine 
        (MEM).''.
                                 <all>